Contralateral biopsy in the management of testicular cancer: what we have learned and what we need to improve

Publisher： John Wiley & Sons Inc

E-ISSN： 2047-2927|3|1|99-101

ISSN： 2047-2919

Source： ANDROLOGY, Vol.3, Iss.1, 2015-01, pp. : 99-101

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Histone deacetylase inhibitors in cancer: What have we learned?

By  

CANCER, Vol. 121, Iss. 8, 2015-04 ,pp. : 1164-1167

John Wiley & Sons Inc

Access to resources Recommend Favorite

Therapeutic vaccines for prostate cancer: what have we learned?

By Gulley James L  

Therapy, Vol. 5, Iss. 1, 2008-01 ,pp. : 3-5

Future Medicine

Access to resources Recommend Favorite

What Have We Learned From Collaborative Partnerships to Concomitantly Improve Both Education and Health?

By  

JOURNAL OF SCHOOL HEALTH, Vol. 85, Iss. 11, 2015-11 ,pp. : 766-774

John Wiley & Sons Inc

Access to resources Recommend Favorite

Primary therapy in breast cancer: what have we learned from landmark trials?

By Bozza Claudia   Osa Etin-Osa   Puglisi Fabio  

Women's Health, Vol. 9, Iss. 6, 2013-11 ,pp. : 583-593

Future Medicine

Access to resources Recommend Favorite

Current Management of Atherosclerotic Renovascular Disease – What Have We Learned from ASTRAL?

By  

Nephron Clin Pract, Vol. 115, Iss. 1, 2010-02 ,pp. : c73-c81

Karger

Access to resources Recommend Favorite